Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)
dc.contributor.author | Ramirez-Fort, Marigdalia K. | |
dc.contributor.author | Gilman, Casey K. | |
dc.contributor.author | Alexander, Jacob S. | |
dc.contributor.author | Meier-Schiesser, Barbara | |
dc.contributor.author | Gower, Arjan | |
dc.contributor.author | Olyaie, Mojtaba | |
dc.contributor.author | Vaidya, Neel | |
dc.contributor.author | Vahidi, Kiarash | |
dc.contributor.author | Li, Yuxin | |
dc.contributor.author | Lange, Christopher S. | |
dc.contributor.author | Fort, Migdalia | |
dc.contributor.author | Deurdulian, Corinne | |
dc.date.accessioned | 2024-03-18T16:23:06Z | |
dc.date.available | 2024-03-18T16:23:06Z | |
dc.date.issued | 2024-02-09 | |
dc.identifier.citation | Ramirez-Fort MK, Gilman CK, Alexander JS, Meier-Schiesser B, Gower A, Olyaie M, Vaidya N, Vahidi K, Li Y, Lange CS, Fort M, Deurdulian C. Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1). Front Med (Lausanne). 2024 Feb 9;10:1304718. doi: 10.3389/fmed.2023.1304718. PMID: 38444631; PMCID: PMC10913592. | en_US |
dc.identifier.eissn | 2296-858X | |
dc.identifier.doi | 10.3389/fmed.2023.1304718 | |
dc.identifier.pmid | 38444631 | |
dc.identifier.pii | 10.3389/fmed.2023.1304718 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/14738 | |
dc.language.iso | en_US | en_US |
dc.publisher | Frontiers Media SA | en_US |
dc.relation.url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/full | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | General Medicine | en_US |
dc.subject | disease-inclusive language | en_US |
dc.subject | folate hydrolase-1 | en_US |
dc.subject | gender-inclusive language | en_US |
dc.subject | prostate-specific membrane antigen | en_US |
dc.subject | theragnostic target | en_US |
dc.title | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Frontiers in Medicine | en_US |
dc.source.volume | 10 | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2024-03-18T16:23:08Z | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Radiology | en_US |
dc.description.degreelevel | N/A | en_US |